Cochlear (ASX:COH) reported Friday that its six-month earnings per diluted share rose to AU$3.125 from AU$2.913 per diluted share a year earlier.
Analysts polled by Visible Alpha were expecting EPS of AU$3.17.
Underlying earnings were AU$3.139 per basic share, compared with AU$2.925 a year earlier.
Total revenue for the half year ended Dec. 31, 2024, was AU$1.17 billion, compared with AU$1.1 billion a year earlier. Analysts surveyed by Visible Alpha expected total revenue of AU$1.2 billion.
Sales revenue was AU$1.17 billion, up from AU$1.11 billion in the same period a year earlier.
The medical device firm expects 2025 underlying net profit at the lower end of the AU$410 million to AU$430 million guidance provided in August 2024. It also expects cochlear implant unit growth of around 10%.
The board declared an interim dividend of AU$2.15 per share, up from the AU$2 in the previously reported period, payable on April 14 to shareholders on record as of March 21.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。